European Psychiatry
June 1, 2026
Z. Onat, Ş. Kükürt
Introduction Multiple sclerosis (MS) is a chronic neuroinflammatory disorder frequently associated with psychiatric comorbidities such as depression, anxiety, bipolar disorder, and psychosis. However, dissociative disorders in MS are rarely reported and remain underexplored. Dissociative amnesia accompanied by regressive behaviors is likely influenced by both the psychological burden of MS and...
European Psychiatry
June 1, 2026
J. Völflová Motlová, M. Janoušková
Introduction Mindfulness can be defined as the ability to be aware of what is happening in the present moment, non-judgmentally. Active mindfulness training for mental healthcare professionals can lead to stress and anxiety reduction and, conversely, increase their empathy, trait mindfulness, and self-compassion. These attributes contribute to the prevention and reduction of burnout syndrome....
European Psychiatry
June 1, 2026
E. B. Avaner, B. Koparal
Introduction Electroconvulsive therapy (ECT) is a well-known intervention for treatment resistant mood disorders but not indicated for dissociative disorders. To date, only few case reports have described incidental improvements in dissociative symptomatology following ECT administered for comorbid depression. Emerging neuroimaging evidence suggests that ECT modulates large-scale brain networks...
European Psychiatry
June 1, 2026
Alexandros Argyriadis, E. Kleanthous, E. Patelarou et al.
Introduction Digital addiction, particularly in the context of excessive smartphone and social media use, has been associated with impaired cognitive control, emotional dysregulation, and social withdrawal. Cognitive Behavioral Therapy (CBT) is widely recognized for addressing maladaptive thought patterns, while mindfulness-based strategies enhance present-moment awareness and reduce...
European Psychiatry
June 1, 2026
J. Chapelas, L. Costa, M. Alves et al.
Introduction The expanding use of cannabis, in both recreational and medicinal contexts, highlights a dual reality of therapeutic potential and clinical concern. On one side, cannabinoids show promising medical applications, including chronic pain relief and antiemetic effects. On the other, cannabis consumption is linked to a broad spectrum of adverse outcomes. Psychiatric effects range from...
European Psychiatry
June 1, 2026
J. Tripp, G. Smagin
Introduction MM120 (lysergide D-tartrate, LSD, CAS 32426-57-6) is under development as a potential treatment for generalized anxiety disorder and major depressive disorder. MM120 may elicit profound lasting psychological changes through interaction with brain 5-HT1A, 1B, 2A, 2C, 6 and 7 receptors, among others, while the complete mechanism is not clear. Objectives The study was performed to...
European Psychiatry
June 1, 2026
T. Jendričko, N. Sutara, A. Matić et al.
Introduction Maladaptive Daydreaming (MD) is a relatively new and still under-recognized phenomenon. It is characterized by prolonged and emotionally engaging immersion in highly structured fantasies. Unlike normal daydreaming, MD involves narrative scenarios with complex characters and plots that may extend into real life. Individuals often spend hours per day in such fantasies, typically...
BJPsych Open
June 1, 2026
Jessie Muchoki
Aims: REM sleep behaviour disorder (RBD) is characterised by loss of physiological REM atonia, resulting in dream-enactment behaviours that may be violent and pose significant risk to patients and bed partners. RBD may be idiopathic, secondary to neurological disease, or medication-induced. Medications, including antidepressants and sedative-hypnotics, have been implicated in precipitating or...
Ophthalmology
June 1, 2026
Jessica G. Shantha, Isabel Ray, Anika Kumar et al.
OBJECTIVE To evaluate the effect of a digital mindfulness-based program (Calm Health) on mental health outcomes in adults with non-infectious uveitis (NIU). DESIGN Single-center, single-masked, waitlist-controlled randomized clinical trial. PARTICIPANTS One hundred adults aged ≥18 years with active or inactive NIU and baseline mild or greater anxiety or depression were randomized 1:1 to...
BJPsych Open
June 1, 2026
Sarah Shackleton, Onuswale Oni, Stephen J. Kaar
Aims: Recreational ketamine use and treatment-seeking for associated complications is increasing in England. Complications of ketamine dependence can be debilitating, leading to continued dependence and surgical intervention. However, treatment remains under-researched, with lacking understanding of those seeking treatment or requiring specialist inpatient detoxification. This study aims to...